Redirecting therapeutic T cells against myelin-specific T lymphocytes using a humanized myelin basic protein-HLA-DR2-zeta chimeric receptor. (Journal of Immunology, 2008)

(untitled) - Moisini, I; Nguyen, P; Fugger, L; Geiger, T